Jpmorgan Chase & CO Royalty Pharma PLC Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Royalty Pharma PLC stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,435,048 shares of RPRX stock, worth $51.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,435,048

Previous 1,395,242 2.85%

Holding current value

$51.5 Million

Previous $35.6 Million 25.51%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$25.75 - $33.86 $1.03 Million - $1.35 Million	39,806 Added 2.85%	1,435,048 $44.7 Million
Q4 2024 Feb 12, 2025	BUY	$24.28 - $28.39 $2.57 Million - $3 Million	105,824 Added 8.21%	1,395,242 $35.6 Million
Q3 2024 Dec 26, 2024	SELL	$25.63 - $29.27 $165 Million - $189 Million	-6,449,863 Reduced 83.34%	1,289,418 $36.5 Million
Q3 2024 Nov 08, 2024	SELL	$25.63 - $29.27 $165 Million - $189 Million	-6,449,863 Reduced 83.34%	1,289,418 $36.5 Million
Q2 2024 Dec 26, 2024	BUY	$26.26 - $29.9 $169 Million - $193 Million	6,449,863 Added 500.22%	7,739,281 $204 Million
Q2 2024 Aug 12, 2024	SELL	$26.26 - $29.9 $6.72 Million - $7.65 Million	-255,818 Reduced 3.2%	7,739,281 $204 Million
Q1 2024 Dec 26, 2024	BUY	$27.46 - $31.33 $184 Million - $210 Million	6,705,681 Added 520.05%	7,995,099 $243 Million
Q1 2024 May 10, 2024	SELL	$27.46 - $31.33 $19.4 Million - $22.1 Million	-705,220 Reduced 8.11%	7,995,099 $243 Million
Q4 2023 Dec 26, 2024	BUY	$26.21 - $29.22 $194 Million - $217 Million	7,410,901 Added 574.75%	8,700,319 $244 Million
Q4 2023 Feb 12, 2024	SELL	$26.21 - $29.22 $4.91 Million - $5.47 Million	-187,248 Reduced 2.11%	8,700,319 $244 Million
Q3 2023 Nov 14, 2023	BUY	$26.26 - $31.38 $3.98 Million - $4.75 Million	151,396 Added 1.73%	8,887,567 $241 Million
Q2 2023 Aug 11, 2023	BUY	$29.6 - $36.56 $1.91 Million - $2.36 Million	64,608 Added 0.75%	8,736,171 $269 Million
Q1 2023 May 18, 2023	BUY	$32.77 - $39.4 $502,036 - $603,608	15,320 Added 0.18%	8,671,563 $312 Million
Q1 2023 May 11, 2023	BUY	$32.77 - $39.4 $7.59 Million - $9.12 Million	231,496 Added 2.75%	8,656,243 $312 Million
Q4 2022 Feb 13, 2023	BUY	$39.17 - $44.04 $3.65 Million - $4.1 Million	93,150 Added 1.12%	8,424,747 $333 Million
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $27.3 Million - $30.5 Million	683,612 Added 8.94%	8,331,597 $335 Million
Q2 2022 Aug 11, 2022	BUY	$37.53 - $44.22 $78.4 Million - $92.4 Million	2,088,597 Added 37.57%	7,647,985 $322 Million
Q1 2022 May 11, 2022	BUY	$37.46 - $42.44 $5.14 Million - $5.82 Million	137,185 Added 2.53%	5,559,388 $217 Million
Q4 2021 Feb 10, 2022	BUY	$35.17 - $42.48 $3.72 Million - $4.49 Million	105,721 Added 1.99%	5,422,203 $216 Million
Q3 2021 Nov 12, 2021	BUY	$36.14 - $42.24 $192 Million - $225 Million	5,316,482 New	5,316,482 $192 Million

Others Institutions Holding RPRX

# of Institutions

496

Shares Held

306M

Call Options Held

1.99M

Put Options Held

384K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $15.7B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Royalty Pharma PLC Transaction History